PR7V10 (ras-12 Ala) Peptide
A natural or synthetic peptide derived from the Ras protein with potential use in cancer immunotherapy. Ras protein regulates a number of signalling molecules by translocating them to the plasma membrane for activation and may serve as a branchpoint in signal transduction because it orchestrates the activity of multiple signalling pathways to regulate diverse cellular functions. Ras-12 Ala is a mutated form of the wild-type Ras protein in which the amino acid glycine at codon 12 is replaced with alanine. Vaccination with mutated Ras proteins or peptides may stimulate cytotoxic host immune responses to tumor cells that express similarly mutated Ras proteins. (NCI04) [ ]
Term info
PR7V10 (ras-12 Ala) Peptide
- PR7V10 (ras-12 Ala) Peptide
PR7v10_ras_12Ala_Peptide
706864
PR7V10 (ras-12 Ala) Peptide
Pharmacologic Substance, Amino Acid, Peptide, or Protein
C1518812
C2796
Term relations
- Mutated Ras Peptide
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation